CXCL9 and IL-18 levels suggested that patients with PNP-deficiency may have a subclinical activation of the IFNγ pathway and indeed they are predisposed to develop sHLH. This evidence concerns the gene CXCL9 and purine nucleoside phosphorylase deficiency.